Home/Filings/4/0001809519-24-000189
4//SEC Filing

Hirsch Douglas Joseph 4

Accession 0001809519-24-000189

CIK 0001809519other

Filed

Oct 27, 8:00 PM ET

Accepted

Oct 28, 5:32 PM ET

Size

11.7 KB

Accession

0001809519-24-000189

Insider Transaction Report

Form 4
Period: 2024-10-26
Transactions
  • Award

    Class A Common Stock

    2024-10-26+20,597147,946 total
  • Award

    Restricted Stock Unit

    2024-10-26+61,56361,563 total
    Class A Common Stock (61,563 underlying)
  • Award

    Class A Common Stock

    2024-10-26+797127,349 total
Holdings
  • Class A Common Stock

    (indirect: By DH 2024 GRAT)
    2,632,721
  • Class A Common Stock

    (indirect: By CH 2024 GRAT)
    2,632,721
Footnotes (6)
  • [F1]Reflects deferred stock units. Each deferred stock unit represents a contingent right to receive one share of Class A common stock. The deferred stock units will vest in approximately equal monthly installments over three months beginning on October 31, 2024, subject to continued service through the applicable vesting date. The deferred stock units will settle on the earliest to occur of the following events (i) December 31, 2027; (ii) Separation from Service; (iii) a Change in Control; (iv) Death; or (v) Disability (each, as defined under the GoodRx Holdings, Inc. Deferred Compensation Plan for Directors).
  • [F2]Reflects restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Class A common stock. The restricted stock units vest in full on the earlier of (i) June 6, 2025 and (ii) the date of the 2025 Annual Meeting of Stockholders, subject to continued service through the applicable vesting date.
  • [F3]Share held directly by DH 2024 GRAT, a grantor retained annuity trust (the "DH 2024 GRAT"). The Reporting Person serves as the sole trustee and sole annuitant of the DH 2024 GRAT.
  • [F4]Share held directly by CH 2024 GRAT, a grantor retained annuity trust (the "CH 2024 GRAT"). Chona Hirsch, the Reporting Person's spouse, serves as the sole trustee and sole annuitant of the CH 2024 GRAT. The Reporting Person has no pecuniary interest in or voting or investment control over the shares of Class A Common Stock held by the CH 2024 GRAT and disclaims beneficial ownership of such shares. This filing is not an admission or acknowledgment that the Reporting Person is the beneficial owner of such shares.
  • [F5]Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
  • [F6]The restricted stock unit award vests as to one-third of the shares underlying the award on each of the first three anniversaries of the grant date, beginning on October 26, 2025, subject to continued service through the applicable vesting date.

Issuer

GoodRx Holdings, Inc.

CIK 0001809519

Entity typeother

Related Parties

1
  • filerCIK 0001822522

Filing Metadata

Form type
4
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 5:32 PM ET
Size
11.7 KB